| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851103 | American Journal of Kidney Diseases | 2009 | 11 Pages |
Abstract
A change to use of AMLs may improve clinical outcomes; however, additional study of associated bacterial resistance is needed before AML use becomes standard care.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Saib A. MRCP, Imad A. FRACP, Susan L. FRCPA, Elizabeth M. MBChB, Bruce B. FRACP, Walter M. FRACP, Mark R. FRACP,